Genotyping was performed using the Illumina (San Diego, CA, USA) HumanOmni2.5–8 array containing approximately 2.5 million markers and scanned using an Illumina HiScan System. Samples with a call rate of < 95% or whose sex differed from the sex determined by X-chromosome homozygosity were excluded from the analysis. SNPs with a call rate of < 95% were excluded from analysis. None of the ANK3 SNPs had Hardy-Weinberg equilibrium (HWE) test p-values < 0.00014—the Bonferroni-corrected significance threshold for the 358 SNPs examined within ANK3. None of the SNPs reported in table 1 had HWE test p-values < 0.01.
